Evaluating the Impact of Autologous Stem Cell Transplantation on Quality of Life in Multiple Sclerosis
A study analyzed the effects of autologous hematopoietic stem cell transplantation (ASCT) on quality of life in multiple sclerosis (MS) patients, finding statistically significant improvements in several physical health measures one year post-treatment.
